More articles from Departments

Oh, What Times We Live In!

Comparison of Usability, Accuracy, Preference, and Satisfaction Among Three Once-Weekly GLP-1 Receptor Agonist Pen Devices

Erratum: Short-Term Outcomes for Veterans Receiving Basal Insulin, Metformin, and a Sulfonylurea Who Are Started on a Third Noninsulin Agent Versus Prandial Insulin. Diabetes Spectrum 2018;31:261–266 (doi.org/10.2337/ds17-0068)

InPen Smart Insulin Pen System: Product Review and User Experience